Trailing-twelve-month (TTM) revenue is $25.01 Billion with a year-over-year growth of +12.51%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $6,199,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $6,068,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-13 |
| Q1 FY2026Period ended 2026-03-31 | $6,080,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $6,665,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $25,012,800,000 |
Current P/S: $17,364,490,537 market capitalization ÷ $25,012,800,000 TTM revenue = 0.69x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $6.67B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:16:12.711Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Corporate Segment | N/A | $0 | $0 | N/A | N/A | N/A |
| CSS | $3.3B | $5.7B | $6.4B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CANADA | $1.9B | $2.7B | $3.0B | $3.0B | $2.9B | $3.2B |
| UNITED STATES | $9.1B | $13.2B | $15.9B | $16.6B |
$25.01B
$25.01 Billion
+12.51%
vs. $22.23B a year ago (TTM)
+8.15%
5 Year compound annual growth rate
1 Year
+12.51%
3 Year
+3.94%
5 Year
+8.15%
10 Year
+12.84%
15 Year
+10.48%
20 Year
+8.42%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $23.51B | +$1.69B | +7.76% |
| 2024 | $21.82B | ($566.40M) | (2.53%) |
| 2023 | $22.39B | +$965.10M | +4.51% |
| 2022 | $21.42B | +$3.20B | +17.58% |
| 2021 | $18.22B | +$5.89B | +47.80% |
| 2020 |
TTM Growth
+12.51%
3-Year CAGR
+3.94%
5-Year CAGR
+8.15%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:16:12.711Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $7.2B |
| $7.5B |
| $9.1B |
| EES | $5.5B | $7.6B | $8.8B | $8.6B | $8.5B | $9.0B |
|---|
| UBS | $3.5B | $4.9B | $6.2B | $6.6B | $5.7B | $5.5B |
|---|
| $17.4B |
| $12.33B |
| +$3.97B |
| +47.46% |
| 2019 | $8.36B | +$182.32M | +2.23% |
| 2018 | $8.18B | +$497.58M | +6.48% |
| 2017 | $7.68B | +$343.00M | +4.68% |
| 2016 | $7.34B | ($182.47M) | (2.43%) |
